NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Wockhardt Limited (NSE: WOCKPHARMA)
WOCKPHARMA Technical Analysis
5
As on 26th Apr 2024 WOCKPHARMA SHARE Price closed @ 573.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1015.24 & Strong Sell for SHORT-TERM with Stoploss of 1045.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
WOCKPHARMASHARE Price
Open | 576.00 | Change | Price | % |
High | 595.00 | 1 Day | 3.10 | 0.54 |
Low | 565.00 | 1 Week | -9.10 | -1.56 |
Close | 573.75 | 1 Month | 42.45 | 7.99 |
Volume | 440684 | 1 Year | -1370.75 | -70.49 |
52 Week High 1944.50 | 52 Week Low 322.45 |
NSE INDIA Most Active Stocks
IDEA | 14.00 | 0.72% |
YESBANK | 26.15 | 0.77% |
IRFC | 158.05 | 5.19% |
GMRINFRA | 90.75 | 6.58% |
HUDCO | 228.10 | 12.34% |
MAHABANK | 67.65 | 3.68% |
SAIL | 168.55 | 2.18% |
NHPC | 92.55 | 1.65% |
TATASTEEL | 165.80 | -1.13% |
IDFCFIRSTB | 84.80 | 1.68% |
NSE INDIA Top Gainers Stocks
ROSSELLIND | 468.35 | 20.00% |
MGEL | 23.25 | 19.85% |
KIRLOSIND | 5232.65 | 12.84% |
HUDCO | 228.10 | 12.34% |
DPABHUSHAN | 1133.45 | 10.42% |
KECL | 130.60 | 10.30% |
EXCEL | 0.55 | 10.00% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
ACL | 98.15 | 9.79% |
NSE INDIA Top Losers Stocks
LTTS | 4778.10 | -7.81% |
BAJFINANCE | 6731.20 | -7.73% |
DBSTOCKBRO | 50.90 | -5.91% |
COMPUSOFT | 33.95 | -5.56% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
KSB | 4674.75 | -5.21% |
WOCKPHARMA Daily Charts |
WOCKPHARMA Intraday Charts |
Whats New @ Bazaartrend |
WOCKPHARMA Free Analysis |
|
WOCKPHARMA Important Levels Intraday
RESISTANCE | 631.56 |
RESISTANCE | 613.02 |
RESISTANCE | 601.56 |
RESISTANCE | 590.10 |
SUPPORT | 557.40 |
SUPPORT | 545.94 |
SUPPORT | 534.48 |
SUPPORT | 515.94 |
WOCKPHARMA Target April 2024
4th UP Target | 2724.94 |
3rd UP Target | 2474.65 |
2nd UP Target | 2319.94 |
1st UP Target | 2165.23 |
1st DOWN Target | 1723.78 |
2nd DOWN Target | 1569.07 |
3rd DOWN Target | 1414.36 |
4th DOWN Target | 1164.07 |
WOCKPHARMA Weekly Target
4th UP Target | 708.11 |
3rd UP Target | 667.94 |
2nd UP Target | 643.11 |
1st UP Target | 618.28 |
1st DOWN Target | 547.43 |
2nd DOWN Target | 522.60 |
3rd DOWN Target | 497.77 |
4th DOWN Target | 457.60 |
WOCKPHARMA Target2024
4th UP Target | 2724.94 |
3rd UP Target | 2474.65 |
2nd UP Target | 2319.94 |
1st UP Target | 2165.23 |
1st DOWN Target | 1723.78 |
2nd DOWN Target | 1569.07 |
3rd DOWN Target | 1414.36 |
4th DOWN Target | 1164.07 |
Wockhardt Limited ( NSE INDIA Symbol : WOCKPHARMA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
WOCKPHARMA Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 33.92 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 267.63 | |
10 Day Avg Volume | Traded -12.49 % Less then 10 Day Average Volume |
WOCKPHARMA Other Details
Segment | EQ | |
Market Capital | 47977787392.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
WOCKPHARMA Address
WOCKPHARMA Latest News
WOCKPHARMA Business Profile
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. The company offers generic products comprising injectables, such as cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of infectious disease, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited. Address: Wockhardt Towers, Mumbai, India, 400051
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service